134 related articles for article (PubMed ID: 5467817)
1. [Long-term testing of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride with special reference to the effect on blood pressure and carbohydrate metabolism].
Krämer D; Krause W; Renner H
Arzneimittelforschung; 1970 Apr; 20(4):519-21. PubMed ID: 5467817
[No Abstract] [Full Text] [Related]
2. [Behavior of hemodynamic values of patients with hypertension during dichlorphenylamino-imidazoline therapy].
Pozenel H
Wien Klin Wochenschr; 1969 Mar; 81(11):187-92. PubMed ID: 4935483
[No Abstract] [Full Text] [Related]
3. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
Knobloch H; Moor H
Arzneimittelforschung; 1966 Sep; 16(9):1169-74. PubMed ID: 6014737
[No Abstract] [Full Text] [Related]
4. Clinical observations on a new antihypertensive drug, 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride.
Smet G; Hoobler SW; Sanbar S; Julis S
Am Heart J; 1969 Apr; 77(4):473-8. PubMed ID: 5773738
[No Abstract] [Full Text] [Related]
5. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
Borrello G
Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
[No Abstract] [Full Text] [Related]
6. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
Ludwig H
Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
[No Abstract] [Full Text] [Related]
7. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
Fritsch H; Bachmann GW; Lenhard J
Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
[No Abstract] [Full Text] [Related]
8. [Blood pressure and heart rate of rats after repeated treatment with 2-(2,6-dichlorphenylamino)-2-imidazoline].
Walland A
Arzneimittelforschung; 1968 Jul; 18(7):833-6. PubMed ID: 5755830
[No Abstract] [Full Text] [Related]
9. [Controlled long-term study in senile hypertension].
Bergener M; Mittelstaedt A
Arzneimittelforschung; 1970 Oct; 20(10):1542-5. PubMed ID: 5536421
[No Abstract] [Full Text] [Related]
10. Effects of high-dose medroxyprogesterone treatment given for endometrial carcinoma on carbohydrate metabolism and liver function.
Ylöstalo P; Vehaskari A; Kauppila A; Sotaniemi E
Ann Chir Gynaecol Fenn; 1974; 63(2):93-8. PubMed ID: 4851752
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of moxonidine in mild to moderate hypertension.
Jain S; Malhotra P; Kumari S; Varma S
J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride].
Grabner G; Michalek P; Pokorny D; Vormittag E
Arzneimittelforschung; 1966 Sep; 16(9):1174-9. PubMed ID: 6014738
[No Abstract] [Full Text] [Related]
13. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
Becker-Christensen F; Bang HO; Ditzel J
Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
[No Abstract] [Full Text] [Related]
14. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
15. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
Lotti G; Gianrossi R
Fortschr Med; 1993 Sep; 111(27):429-32. PubMed ID: 8225149
[TBL] [Abstract][Full Text] [Related]
16. [Controllable hypertension therapy with Tadip].
Schütz E
Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
[No Abstract] [Full Text] [Related]
17. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
Lazebnik LB; Malichenko SB; Serebrov AN
Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
[No Abstract] [Full Text] [Related]
18. [Side effects of contraceptive drugs].
Schreiner WE
Schweiz Med Wochenschr; 1970 May; 100(18):778-84. PubMed ID: 5494369
[No Abstract] [Full Text] [Related]
19. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
Sharma AM; Wagner T; Marsalek P
J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experiences with 2-(2,6-dichlorphenylamino)-2-imidazolinhydrochloride in renal hypertension].
Kotzaurek R; Schmidt P; Widhalm F
Wien Klin Wochenschr; 1970 Nov; 82(45):805-9. PubMed ID: 5479019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
